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Abstract
The enteric nervous system (ENS), often regarded as a “second brain”, is the largest 
component of the peripheral nervous system that contains millions of neurons and glia within 
the gut wall and can operate more or less independently of the central nervous system. Control 
of gastrointestinal motility and epithelial secretion are the well-known ENS functions, but 
recent research has elucidated its importance for immune regulation, metabolism, and brain 
homeostasis. Here I review major advances in the understanding of the ENS functions and its 
newly recognized role in various human diseases such as cancer, diabetes, and neurological 
disorders.
はじめに



































（enteric glial cell: EGC）から構成されてい
る。神経細胞は形態的には２種類に分類され












































































































Hirschsprung 病　Hirschsprung 病 は １ 人
/5000 〜１万人の頻度でみられる先天性の肛
門側腸管無神経節症で、直腸からの病変範囲
により short segment type （下部直腸）〜
図 2　A、様々な形態の EGC（細胞選択的に蛍光タンパ





















































することで、がんと ENS との間に positive 


















積（Lewy 小体）が病理学的 hallmark であ
るが、ENS にもこれがみられることは以前
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